Dr. Dr. Mai-Kim Gervais
Claim this profileHopital Maisonneuve Rosemont
Studies Retroperitoneal Sarcoma
Studies Leiomyosarcoma
3 reported clinical trials
5 drugs studied
Area of expertise
1Retroperitoneal Sarcoma
MDM2 positive
CDK4 positive
CINSARC-high positive
2Leiomyosarcoma
MDM2 positive
CDK4 positive
CINSARC-high positive
Affiliated Hospitals
Clinical Trials Dr. Mai-Kim Gervais is currently running
Preoperative Chemotherapy + Surgery
for Sarcoma
This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival. After confirmation of eligibility criteria, patients will be randomized to either the standard arm or experimental arm.
Recruiting2 awards Phase 35 criteria
Surgical Excision Margins
for Melanoma
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.
Recruiting1 award N/A9 criteria
More about Dr. Mai-Kim Gervais
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Dr. Mai-Kim Gervais has experience with
- Preoperative Chemotherapy
- Surgery
- Indocyanine Green
- Wide Local Excision = 1cm Margin
- Wide Local Excision = 2cm Margin
Breakdown of trials Dr. Mai-Kim Gervais has run
Retroperitoneal Sarcoma
Leiomyosarcoma
Uterine Leiomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dr. Mai-Kim Gervais specialize in?
Dr. Mai-Kim Gervais focuses on Retroperitoneal Sarcoma and Leiomyosarcoma. In particular, much of their work with Retroperitoneal Sarcoma has involved MDM2 positive patients, or patients who are CDK4 positive.
Is Dr. Mai-Kim Gervais currently recruiting for clinical trials?
Yes, Dr. Mai-Kim Gervais is currently recruiting for 2 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Dr. Mai-Kim Gervais has studied deeply?
Yes, Dr. Mai-Kim Gervais has studied treatments such as Preoperative chemotherapy, Surgery, Indocyanine Green.
What is the best way to schedule an appointment with Dr. Mai-Kim Gervais?
Apply for one of the trials that Dr. Mai-Kim Gervais is conducting.
What is the office address of Dr. Mai-Kim Gervais?
The office of Dr. Mai-Kim Gervais is located at: Hopital Maisonneuve Rosemont, Montréal, Quebec H1T 2M4 Canada. This is the address for their practice at the Hopital Maisonneuve Rosemont.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.